BACKBLAZE, INC. BLZE 深 沪
等待开盘 12-20 09:30:00 美东时间
4.82
+0.220
+4.78%
华盛通- 最 高4.935
- 今 开4.62
- 成交量 110.13万股
- 最 低 4.62
- 昨 收 4.60
- 总市值 2.78亿
- 52周最高 10.8579
- 市盈率 静 --
- 换手率 1.91%
- 52周最低 3.94
- 委 比 77.19%
- 总股本 5770.00万
- 历史最高 36.50
- 量 比 0.91
- 振 幅 6.85%
- 历史最低 3.50
- 每 手 1
- 风险率 1.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Security Tech Check-In: Analyst Insights From 12 Companies Ahead Of The 'Quiet Period'
Needham analysts met with 12 companies before quiet period. Ratings and price targets by analyst Mike Cikos.
12-19 03:38
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Needham Maintains Buy on Backblaze, Lowers Price Target to $8
Needham analyst Mike Cikos maintains Backblaze (NASDAQ:BLZE) with a Buy and lowers the price target from $12 to $8.
11-07 02:27
Backblaze shares are trading lower after the company reported Q3 financial results and issued Q4 sales guidance below estimates. Also, the company narrowed its FY25 sales guidance below estimates.
Backblaze shares are trading lower after the company reported Q3 financial resu...
11-06 22:30
Backblaze Narrows FY2025 Sales Guidance from $145.000M-$147.000M to $145.400M-$146.000M vs $146.126M Est
Financial Outlook:Based on information available as of the date of this press release,For the fourth quarter of 2025, we expect:Revenue between $37.3 million to $37.9 million.Adjusted EBITDA margin between 20% to
11-06 20:23
Backblaze Q3 Adj. EPS $0.03 Beats $(0.12) Estimate, Sales $37.200M Beat $36.931M Estimate
Backblaze (NASDAQ:BLZE) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.12) by 124.59 percent. This is a 130 percent increase over losses of $(0.10) per share from the same
11-06 20:20
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
美股大行评级 | 潜在最高涨幅37.45%，甲骨文获多家机构上调目标价；瑞穗上调美光科技目标价升至240美元
今日重点评级关注：韦德布什：维持Artiva Biotherapeutics"跑赢大市"评级，目标价从18美元升至23美元；巴克莱：维持Cellectis"超配"评级，目标价从4美元升至8美元
10-20 10:03
Oppenheimer Maintains Outperform on Backblaze, Raises Price Target to $11
Oppenheimer analyst Ittai Kidron maintains Backblaze (NASDAQ:BLZE) with a Outperform and raises the price target from $10 to $11.
10-18 01:52
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
